UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 333-67884

Global Pharmatech, Inc.
(Exact name of registrant as specified in its charter)

509 Maoxiang Street, High-Technology Industrial Development Zone, Changchun, Jilin, People's Republic of China 130012 Tel: +86-431-85541826 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.0001
(Title of each class of securities covered by this form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains.)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend this duty to file reports: 

Rule 12g-4(a)(1)(i) [X] Rule 12g-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) | | Rule 12g-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12g-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12g-3(b)(2)(ii) [ ]

Rule 15d-6 [ ]

Approximate number of holders of record as of the certification or notice date:
278

Pursuant to the requirements of the Securities Exchange Act of 1934 Joning Corp. has caused this certification /notice to be signed on its behalf by the undersigned duly authorized person. 

Date: December 11, 2008 By: /s/ Zhuojun Li
 --------------------------------
 Zhuojun Li, Secretary

Global Pharmatech (PK) (USOTC:GBLP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Global Pharmatech (PK) Charts.
Global Pharmatech (PK) (USOTC:GBLP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Global Pharmatech (PK) Charts.